Therapeutic Advances In Urology impact factor, indexing, ranking (2022)


Therapeutic

Aim and Scope

Therapeutic Advances In Urology is a research journal that publishes research related to Urology. This journal is published by the SAGE. The P-ISSN of this journal is 17562872.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Therapeutic Advances in Urology.

Therapeutic Advances In Urology Ranking

Impact Factor: 3.13
Total Citations: 1115
SJR (SCImago Journal Rank): 1.115
Quartile: Q2

The Impact Factor of Therapeutic Advances In Urology is 3.13.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title: Therapeutic Advances in Urology
Publisher: SAGE
P-ISSN: 17562872
Open Access: YES
Subject: Urology
Citescore: 3.6
SNIP: 1.535
SJR: 1.115
Quartile: 2

Therapeutic Advances in Urology Indexing

The Therapeutic Advances in Urology is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Therapeutic Advances In Urology Impact Factor 2022

The latest impact factor of Therapeutic Advances in Urology is 3.13.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.


Therapeutic Advances In Urology Quartile

The latest Quartile of Therapeutic Advances in Urology is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

Based on the Official Journal Homepage, the publication fee of Therapeutic Advances in Urology is around 2300 USD.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Therapeutic Advances In Urology?

This journal covers the fields/ categories related to Urology. If your research field is related to Urology, then visit the official website of Therapeutic Advances in Urology and send your manuscript.

Tips for publishing in Therapeutic Advances In Urology:

  • Selection of research problem.
  • Presenting a solution.
  • Designing the paper.
  • Make your manuscript publication worthy.
  • Write an effective results section.
  • Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Review Time

Journals usually ask reviewers to provide their reviews within 3-4 weeks. However, few journals have a mechanism to enforce the deadline, which is why it can be hard to predict how long the peer review process will take.

The review time also depends upon the quality of a research paper.


Final Summary

  • The impact factor of Therapeutic Advances in Urology is 3.13.
  • It is published by SAGE.
  • The journal is indexed in UGC CARE, Scopus, SCIE, DOAJ, PubMed.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 1.115.
  • The Therapeutic Advances in Urology is a reputed research journal.

Sources:

https://www.scopus.com/sourceid/19700175203







Similiar Journals


ADVANCES IN UROLOGY
ISSN: 1687-6369
Publisher: HINDAWI LTD

AFRICAN JOURNAL OF UROLOGY
ISSN: 1110-5704
Publisher: SPRINGER

AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY
ISSN: 2330-1910
Publisher: E-CENTURY PUBLISHING CORP

ARAB JOURNAL OF UROLOGY
ISSN: 2090-598X
Publisher: TAYLOR & FRANCIS LTD

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA
ISSN: 1124-3562
Publisher: PAGEPRESS PUBL

ASIAN JOURNAL OF UROLOGY
ISSN: 2214-3882
Publisher: ELSEVIER SINGAPORE PTE LTD

CASE REPORTS IN NEPHROLOGY AND DIALYSIS
ISSN: 2296-9705
Publisher: KARGER

CEN CASE REPORTS
ISSN: 2192-4449
Publisher: SPRINGER JAPAN KK

CENTRAL EUROPEAN JOURNAL OF UROLOGY
ISSN: 2080-4806
Publisher: POLISH UROLOGICAL ASSOC

CURRENT BLADDER DYSFUNCTION REPORTS
ISSN: 1931-7212
Publisher: SPRINGER

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.